Effect of LAAM dose on opiate use in opioid-dependent patients: A pilot study

American Journal on Addictions

Volumn 7, Issue 4, 1998, Pages 272-282

  Oliveto, Alison H ^a,b   Farren, Conor ^a   Kosten, Thomas R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVACETYLMETHADOL; OPIATE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG CROSS TOLERANCE; DRUG URINE LEVEL; ETHNIC GROUP; FEMALE; HUMAN; MALE; NEGRO; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL;

EID: 0031735180     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.1998.tb00346.x     Document Type: Article

References (21)

1. Zweben JE, Payte JT: Methadone maintenance in the treatment of opioid dependence: a current perspective. West J Med 1990; 152:588-599
2. Archer S: Preclinical Studies: Pharmacology of LAAM in Rx: 3x/week LAAM: Alternative to Methadone. NIDA Research Monograph 1976; 8:15-28
3. Fraser HF, Isbell H: Actions and addiction liabilities of alpha-acetylmethadols in man. J Pharmacol Exp Ther 1952; 105:458-465
4. Jaffe JH, Schuster CR, Smith BB, et al: Comparison of acetylmethadol and methadone in the treatment of long-term heroin users: a pilot study. JAMA 1970; 211:1834-1836
5. Billings RE, McMahon RE, Blake DA: I-acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites. Life Sci 1974; 14:1437-1446
6. Ling W, Klett J, Gillis RD: A cooperative clinical study of methadyl acetate, I: three-times-a-week regimen. Arch Gen Psychiatry 1978; 35:345-353
7. Senay EC, Dorus W, Renault PF: Methadyl acetate and methadone: an open comparison. JAMA 1977; 237:138-142
8. Jaffe JH, Senay EC, Schuster CR, et al: Methadyl acetate vs. methadone: a double-blind study in heroin users. JAMA 1972; 222:437-442
9. Sorenson JL, Hargreaves WA, Weinberg JA: Withdrawal from heroin in three or six weeks: comparison of methadyl acetate and methadone. Arch Gen Psychiatry 1982; 39:167-171
10. Ling W, Charuvastra VC, Kaim SC, et al: Methadyl acetate and methadone as maintenance treatments for heroin addicts: a Veterans Administration cooperative study. Arch Gen Psychiatry 1976; 33:709-720
11. Sollod RM, Goldstein G: Clinical Studies: Phase 1, in Rx: 3x/Week LAAM Alternative to Methadone. NIDA Research Monograph Series 1976; pp 8:39-51
12. Zaks A, Fink M, Freedman AM: Levomethadyl in maintenance treatment of opiate dependence: 1972, in Rx: 3x/Week LAAM Alternative to Methadone. NIDA Research Monograph Series 1976; 8:92-93
13. Eissenberg T, Bigelow GE, Strain EC, et al: Doserelated efficacy of levomethadyl acetate for treatment of opioid dependence: a randomized clinical trial. JAMA 1997; 277:1945-1951
14. Kosten TR, Schottenfeld R, Ziedonis D, et al: Buprenorphine vs. methadone maintenance for opioid dependence. J Nerv Ment Dis 1993; 181:358-364
15. Schottenfeld RS, Kosten TR, Pakes J, et al: Buprenorphine vs. methadone maintenance for combined cocaine and opioid dependence. Proceedings of the Committee on Problems of Drug Dependence 1993, NIDA Research Monograph Series 1994; pp 141-142
16. Poklis A: Evaluation of TDx cocaine metabolite assay. J Anal Toxicol 1987; 11:228-230
17. Walters R: An abused drug assay system. Reprinted from American Clinical Products Review, March 1987
18. Gawin FH, Kleber HD: Cocaine abuse treatment: an open pilot trial with lithium and desipramine. Arch Gen Psychiatry 1984; 41:903-909
19. Gawin FH, Kleber HD: Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry 1986; 43:107-113
20. Oliveto AH, Kosten TR, Schottenfeld R, et al: Cocaine use in buprenorphine- vs. methadone-maintained cocaine users. Am J Addict 1994; 3:43-48
21. Schottenfeld RS, Pakes J, Ziedonis D, et al: Buprenorphine: dose-related effects on cocaine and opiate use in cocaine-abusing opiate dependent humans. Biol Psychiatry 1993; 34:66-74